idiopathic-pulmonary-fibrosis

Documents about idiopathic-pulmonary-fibrosis

• To Determine Safety and Tolerability of MG-S-2525 and to Evaluate Its PK Profile in Healthy Volunteers#893837ClinicalTrials.gov
• Study to Evaluate the Effect of GBT440 Administered to Subjects With IPF on Supplemental Oxygen at Rest#1031720ClinicalTrials.gov
• A Study to Assess the Effect of AZD5055 on the Pharmacokinetics (PK) of Nintedanib in Healthy Participants.#857894ClinicalTrials.gov
• A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension#253116ClinicalTrials.gov
• Interstitial Lung Disease: A Study From Infancy to Elderly Including Relatives#967213ClinicalTrials.gov
• Biomarkers of mitochondrial dynamics in idiopathic pulmonary fibrosis: Identification and validation through transcriptomic and single-cell analyses#126098PLOS
• Erratum : Pirfenidone for idiopathic pulmonary fibrosis: A systematic review and meta-analysis (PLoS ONE 10:8 (e0136160) 10.1371/journal.pone.0136160)#277485Repositorio USS
• Toward Self-management in ILD#857222ClinicalTrials.gov
• The Occurence of Inflammation and Oxidative Stress in Lung Diseases#871393ClinicalTrials.gov
• Validation of the C-mo System - Cough Monitoring#813097ClinicalTrials.gov
• Kangxianhuanji formula and its component rutin ameliorate acute exacerbation of idiopathic pulmonary fibrosis by targeting GLUT1 to suppress HIF-1α-mediated glycolysis.#172106NCBI PubMed Central
• Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects#904830ClinicalTrials.gov
• Transcriptomic Profiling of Thymol-Treated TGF-β1-Stimulated Human Lung Fibroblasts#609490Figshare
• Comparative Pharmacokinetic Study of Pirfenidone Modified-Release Tablets and Pirfenidone Tablets in Healthy Subjects Under Fed Conditions#878472ClinicalTrials.gov
• Multi-elemental Imaging of Lung Tissues With LIBS (Laser-induced Breakdown Spectroscopy)#886320ClinicalTrials.gov
• Antifibrotic Efficacy of a Nintedanib-Peptide Conjugate and Diagnostic Potential of a Fluorescent Companion Probe Targeting α(V)β(6) Integrin in Idiopathic Pulmonary Fibrosis.#863NCBI PubMed Central
• Efficacy and safety of RApid PrednIsolone Dose reduction for acute exacerbation of Idiopathic Pulmonary Fibrosis (RAPID-IPF Trial): a study protocol for a randomised controlled trial.#340597NCBI PubMed Central
• Real-world persistence with antifibrotic treatments: a nationwide study on claims data in France (The REPEAT study)#330279HAL (France)
• The NIH Exercise Therapy for Advanced Lung Disease Trials: Response and Adaptation to Aerobic Exercise in Patients With Interstitial Lung Disease#877534ClinicalTrials.gov
• Single-center retrospective cohort study of lung cancer associated with interstitial lung disease: Prognostic factors and molecular profile#171651HAL (France)
• Artificial Intelligence (AI) Detection of Incidental Interstitial Opacity on Chest Radiography#850565ClinicalTrials.gov
• Rôle des acides nucléiques du soi en tant que signaux de danger activant la voie de signalisation STING dans la fibrose pulmonaire idiopathique (FPI)#246734HAL (France)